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Introduction
An individual’s sexual response can be affected in a number of 
ways that involves the physical, psychological, interpersonal, 
and behavioural aspects of a person. The most common 
sexual problems for people who have cancer are loss of 
desire for sexual activity in both men and women, problems 
achieving and maintaining an erection in men, and pain with 
intercourse in women (1). Unlike many other physiological 
side effects of cancer treatment, sexual problems do not 
tend to resolve within the first year or two of disease-free 
survival (2-5) rather, they may remain constant and fairly 
severe or even continue to increase. Long-term effects of 
different treatment on sexual functioning have been studied 
in cervical cancer survivors (6,7). Existing research has 
mainly focused on women who have breast or gynecologic 
cancer and men who have prostate cancer (8). Less is known 
about how other types of cancers affect sexual health. 
Although it is unclear how much sexual problems influence 
a survivor’s rating of overall health-related quality of life, 
these problems are clearly bothersome to many patients 
and interfere with a return to normal post-treatment life. 
In 2014, the National Cancer Institute at the National 
Institutes of Health published data on some form of sexual 
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dysfunction occurring in 40-100% of persons diagnosed 
with cancer (1,9-13). Sexual dysfunction is less broadly 
defined than sexuality and is characterized by dysfunction of 
one of the four phases of the sexual response cycle, or pain 
during intercourse (14,15). The World Health Organization 
(WHO) defines sexuality as a central aspect of being human 
throughout life and encompasses sex, gender identities 
and roles, sexual orientation, eroticism, pleasure, intimacy 
and reproduction. Comparatively, sexual health is defined 
as a state of physical, emotional, mental and social well-
being relating to sexuality, and is not merely the absence of 
disease, dysfunction or infirmity (16). Cancer and cancer 
therapies are frequently associated with changes in sexual 
health. However, there is a lack of consensus regarding valid 
outcome measures for assessing sexual functioning in cancer 
patients (12,17). There is no single self-report measure that 
can be recommended for cancer clinical trials (18,19) on 
the basis of a broader definition of sexual health. Several 
modules for various cancer sites (e.g., breast, gynecologic, 
prostate) were developed by the European Organisation 
for Research and Treatment of Cancer Quality of Life 
Group (EORTC-QLG) which include a limited number of 
sexual functioning items. The U.S. National Institutes of 
Health PROMIS® Network has already developed a self-
report measure of sexual function and satisfaction for cancer 
populations (20). However, the existing questionnaires do 
not cover the whole range of sexual health. Currently, there 
is no comprehensive instrument that assesses aspects of 
sexual health in a broader sense. 
The aim of the study is to develop a comprehensive 
EORTC questionnaire to assess sexual health of male 
and female cancer patients and for cancer survivors. We 
describe the development of the sexual health questionnaire 
according to the EORTC guidelines (21).
Materials and methods
According to the EORTC guidelines (21) the development 
of an EORTC questionnaire is typically organised 
in four phases. The first phases comprise a literature 
search following interviews with patients and health care 
professionals (HCPs) (phase 1) and the operationalization 
into items (phase 2).
Literature search and interviews
The literature search is focused on sexual health in cancer 
patients with a search strategy which was kept broad. The 
following combinations of keywords were used to identify 
papers in PubMed covering the period January 1993 to 
January 2012: ‘neoplasms[mesh]’ or ‘neoplas*[tw]’ or 
‘tumor[tw]’ or ‘tumors[tw]’ or ‘tumou*[tw]’ or ‘cancer*[tw]’ 
or ‘carcinom*[tw]’ or ‘oncolog*[tw]’ and ‘sexuality[mesh]’ 
or ‘sexual function or sexual function[all fields]’ or ‘sexual 
function[tiab]’ or ‘sexual dysfunction’ or ‘sexual dysfunction 
[all fields]’ or ‘sexual dysfunction[tiab]’. Articles focusing on 
sexuality that conceptually exceeds issues relating to sexual 
function, sexual activity or sexual response cycle in cancer 
patients and/or cancer survivors were selected through title 
and abstract screening. For inclusion, original research 
articles had to be full reports in English and published in 
peer-reviewed journals. Qualitative and quantitative studies 
are included in the review. Additionally, an evaluation 
of measures related to sexuality in cancer patients was 
conducted (Den Oudsten et al., unpublished data). Issues 
which resulted from the literature search were summarized 
in an issue list. The same list was then presented to patients 
and HCPs recruited by collaborators within the EORTC 
Quality of Life Group for feedback on appropriateness of 
content and breadth of coverage on a four-point Likert 
scale. The following demographic data from the HCPs 
were asked: professional background, cancer sites they 
were most familiar with, duration of being involved in the 
care of patients with cancer, sex and country. A case report 
form including the most important clinical data related 
to disease and therapy was given to patients. The list of 
issues was translated into several languages. Members 
and collaborators of the EORTC-QLG spread out the 
questionnaire to other HCP specialists in oncology such 
as psycho-oncologists, radiotherapist or gynaecologists in 
more than 20 institutions in different countries (Table 1).
For the final decision which issues on sexual health are 
definitely important for cancer patients, mean scores for 
relevance and priority ratings were defined according to the 
EORTC-QLG guidelines (21) using the following criteria: 
(I) mean score for HCPs <2 versus ≥2; and (II) mean score 
for patients <2 versus ≥2; (III) priority should have been rated 
by more than 30% of the HCPs; and (IV) >30% of patients 
as highly relevant to be included. Issues that met three or 
four of these criteria were kept in the list. Issues that met 
less than three criteria were deleted, unless the interviews 
provided strong arguments for retaining them. Additional 
new issues were included if they were mentioned by a 
considerable number of patients or HCPs. Based on the 
remaining issues the items for the provisional questionnaire 
were developed.
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Table 1 Issue list
Sexual activity
Frequency of sexual activity
Reasons for being sexually inactive
Satisfaction with the frequency of sexual activity
Importance of having an active sexual life
Level of hesitation to initiate sexual activities
Sexual desire
Frequency of sexual desire
Level of desire
Distress caused by decreased libido
Satisfaction with frequency of sexual desire
Satisfaction with level of desire
Sexual arousal
Frequency of sexual arousal
Level of sexual arousal
Satisfaction with level of sexual arousal
Orgasm
Ability to achieve an orgasm
Difficulty to reach an orgasm
Satisfaction with the ability to orgasm
Satisfaction with the frequency of orgasm
Side-effects influencing sexual activity
Incontinence (urine/fecal) during foreplay or intercourse
Hair loss (indirectly) affecting sexual response
Fatigue/lack of energy affecting sex life
Scarring/organ loss (indirectly) affecting sexual response/
satisfaction
Pain
Frequency of pain during/after sexual activity
Level of pain during/after sexual activity
Intimacy
Change in amount of affection expressed
The level of emotional intimacy
Satisfaction with level of affection or intimacy 
Fear
Fear that sex will be painful
Fear of injury during intercourse





Partner is afraid to touch, afraid to cause pain
Experience of emotional distance from spouse
Insecurity regarding ability to satisfy the partner
Partner response to changes in sexual functioning: 
accepting/rejecting
Distress/bothered/satisfaction (general) 
Level of comfort with one’s sexuality
Change in presence sexual fantasies
Level of sexual enjoyment
Sexual satisfaction
Reduced sexual enjoyment
To what extent are sexual dysfunctions distressing
Health care/aids
Need for care because of sexual difficulties







Ability to get an erection
Ability to maintain an erection (firm enough for sex)
Satisfaction with ability to maintain erection or level of 
firmness
Level of confidence in getting an erection and keeping one
Masculinity




Frequency of spotting/bleeding after sexual intercourse
Feminity
Change in femininity/feeling less feminine
Masturbation (included after discussion during an EORTC 
QLG meeting)
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Operationalization into items
The process of translation is formally conducted according 
to the EORTC QLG Translation guidelines with a 
rigorous forward-backward procedure (18) supported by 
native speakers. The underlying English issues will be 
operationalised into items first. If items already have been 
used in another validated EORTC questionnaire they 
normally are included in their original wording. Questions 
are phrased in a way that they fit into the 4-point answering 
format of the EORTC ranging from “not at all” to “very 
much”. A time frame of 4 weeks is chosen as suggested in 
the EORTC guidelines (21). A standardized introduction 
was modified for the issue of sexual health.
Phase 3 is the pilot-testing of the final item list 
and is actually under construction. A validation of the 
questionnaire will be done in phase 4. 
Results
Results of the literature search 
Many generic and cancer-specific sexual health issues have 
been identified in the literature review. A total of 4,518 
articles were screened of which 3,461 articles were excluded 
because they did not focus on cancer patients and/or did 
not report sexuality as an outcome measure. Another 924 
articles were excluded because they were literature reviews 
or presented only domain scores or were on sexual activity 
and sexual response cycle only. Finally, 65 articles were 
included in the systematic review. Apart from the frequency 
of sexual activity, sexual dysfunction and overall levels of 
satisfaction with sexual functioning, a number of issues 
were identified: sex-related guilt, anxiety, embarrassment, 
future prospects, quality of the relationship with the 
partner, changed feelings of sexual attractiveness, partner’s 
response to the changed situation, and the effectiveness 
and side effects of (medical) sex aids. These topics were 
used as underlying issues for the provisional sexual health 
questionnaire.
Issues concerning sexual attractiveness were restricted 
to quantitative studies only. Many questionnaires for 
measuring different aspects of sexual health were found in 
the reviewed literature, but cancer-specific instruments were 
underrepresented. Sexual functioning was often assessed 
as part of (health-related) quality of life. Frequencies and 
sexual satisfaction were commonly assessed with a single 
item only. Qualitative designs to assess sexual functioning 
were used in 20 studies. The detailed results of the literature 
review are described elsewhere (Den Oudsten et al., 
unpublished data). Issues identified by the literature search 
were first checked for clinical relevance. A shortened list of 
53 issues was then reviewed by a great number of patients 
(n=107) and HCPs (n=83).
 
Characteristics of patients and HCPs
Most of the patients had breast cancer (n=43; 40%), 
followed by colorectal (n=17; 16%), and head and neck 
cancer (n=14; 13%). All over the group cancer sites were 
well-balanced. The majority of patients were treated with 
surgery followed by radiation therapy and chemotherapy, 
and were under active treatment when they were 
interviewed. Half of the patients had no evidence of disease 
(n=53; 50%); a smaller number was newly diagnosed (n=17; 
16%) or had a recurrent disease (n=11; 10%). A progression 
was stated for 10 patients. About a half had completed their 
treatment within the last 5 years, 8% more than 5 years ago 
and the others have not completed yet or did not provide 
any information on that. There were more female than 
male patients interviewed with a mean of 55 years (±11). 
The majority was living with a partner or family and had a 
sexual partner and was well-educated (Tables 2,3).
Various experts from different disciplines, mainly 
employed as medical doctors (n=53; 64%), psycho-
oncologists (n=16; 21%) or nurses (n=3), reviewed the 
issue list. Gender was equally distributed and their clinical 
experiences mostly ranged from 10 to 20 years. Most of the 
HCPs were familiar with gynecologic cancer (n=29; 26%), 
followed by colorectal/gastrointestinal (n=21; 19%), breast 
(n=18; 16%), prostate/testicular (n=9; 8%) and other cancer 
sites (e.g., head and neck or lung cancer) (n=33; 31%).
Interview results
Most of the issues on satisfaction as well as the importance 
of having an active sexual life were rated as highly important 
in the sexual health questionnaire by both patients and 
HCPs. There were several issues referring to satisfaction 
(e.g., satisfaction with the level of affection or intimacy, 
satisfaction with the frequency of sexual activity, satisfaction 
with the communication with the partner and sexual 
satisfaction). No specific issues for female patients were 
rated as highly important. Male patients additionally rated 
their level of confidence in getting an erection and keeping 
one as very important. These issues met all four criteria on 
relevance and priority. Issues on sexual arousal, orgasm-
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related issues and general issues on sexual enjoyment were 
also rather important for female and male patients and 
HCPs. 
A very low relevance and priority had the issues on hair 
loss, masturbation and sexual desire (frequency, level). Also 
issues about fear harming the incision during intercourse, 
retrograde ejaculation and changes in sexual fantasies did 
not fulfill the criteria to be further included.
When considering the mean relevance only, all presented 
issues except five were more often rated as highly relevant 
for cancer patients by HCPs than by patients. There seems 
to be a similar relevance for sexual desire (frequency, level), 
satisfaction (with level of affection or intimacy and with the 
communication with the partner) and the level of emotional 
intimacy. All other issues were rated more relevant to be 
included in the questionnaire for HCPs, not for patients. 
The greatest differences in the estimated relevance 
(>1.10) were found for issues on incontinence, masturbation, 
pain and fear, always rated higher by the interviewed 
HCPs (>1.0). Comparable results were found for issues for 
male sexual health (ejaculation) and issues on masculinity/
femininity (Tables 4,5).
Priority for inclusion was assessed in the same way for 
most of the 53 issues from the list. Only level of emotional 
intimacy and change in amount of affection expressed was 












Living with partner or family 90 84
Living alone 14 13







Post compulsory school education 47 44
University level 30 28
Compulsory school education or less 24 22
Missing 6 6
Table 3 Clinical patient characteristics (N=107)
Characteristics N %
Treatment status
Active treatment 72 67




Radiation therapy 66 62
Chemotherapy 62 58
Anti-hormonal therapy 28 26
Others 5 5
Status of disease
No evidence of disease 53 50





Less than 5 years ago 80 75
5 to 10 years ago 20 19
More than 10 years ago 3 3
Missing 4 4
Time of completion
During the last  5 years 45 42
More than 5 years ago 9 8





Treatment-related menopause 13 20
Missing 4 6
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much more higher prioritised by patients than by HCPs. 
Although many issues on body-related changes were less 
relevant for patients on average, they thought that these 
topics should be included in such a questionnaire of sexual 
health for cancer patients anyway (e.g., incontinence).
Highest differences in the evaluated issues, identified for 
relevance and priority, were found for frequency of pain 
(during/after sexual activity), incontinence, fear that sex 
will be painful, and for communication about sexual issues 
with HCPs. While the interviewed HCPs found those 
issues more important to integrate in the sexual health 
questionnaire, patients found them less relevant. 
Item development
On the basis of the results a provisional item list was 
established (“EORTC SHQ-Cxx”), supported by the 
translation coordinator of the EORTC Quality of Life 
Department. Issues fulfilling all four criteria on relevance 
and priority were automatically included. Issues within the 
categories of sexual desire, sexual arousal and pain were 
combined each. Issues implying norms, such as frequencies 
or content-related redundancy were not included. Negative 
wording or ambiguity was additional reasons for exclusion. 
The reduced list of 22 items with an additional question on 
reasons for not being sexually active was reviewed by two 
independent native English speakers before starting the 
translations process. At least three languages representing 
an English-speaking country, a country from Northern 
and Southern Europe were invited for preparation of pilot-
testing, which is the next step in the EORTC procedure to 
develop a validated EORTC questionnaire.
Discussion
The results of the literature search were considered for 
the development of the issue list which was presented to 
patients and HCPs. Interview results were then analysed 
and item development process was done before continuing 
with pretesting. 
Studies on sexuality in oncology patients which were 
found in the literature search predominantly focused on 
issues of activity, experiences of sexual dysfunction, and 
satisfaction with sexual functioning. The literature review 
identified themes beyond these aspects and provided 
interesting results on current instruments used for 
measuring sexual health. No questionnaire currently exists 
that focuses on physical, psychological, and social aspects 
of sexuality for cancer survivors. Based on the available 
interview results most important issues to fill this gap were 
identified: satisfaction and the importance of having an 
active sexual life such as the level of confidence in getting 
an erection and keeping one for male patients. Different 
evaluations by HCPs and patients were found for most of 
the issues. Pain, incontinence, fear and communication 
about sexual issues with HCPs were issues which were 
highly relevant for HCPs but not for patients. Less research 
exists, in which possible reasons have been identified. 
Body image can change during different phases of cancer 
treatment. As shown in a review article by Cororve Gingeret 
et al. 2014 (22) patients are found to be most concerned 
about body image in the immediate postoperative period 
and soon after completing other forms of treatment (23). 
In a study with 225 Canadian cancer patients, 44% used 
the Internet to learn more about their condition and 14% 
wished their medical teams had provided them with links, 
but did not independently search for medically relevant 
information about their condition. While education level 
was correlated with web based information seeking, age 
was not (24). Why fear as an issue was less important for 
our interviewed patients than for professionals would be 




Frequency of sexual desire 1.76 1.76
Level of desire 1.70 1.79
Satisfaction with level of affection or intimacy 2.24 2.31
The level of emotional intimacy 2.10 2.13
Satisfaction communication partner 2.35 2.43
HCPs, health care professionals.







Frequency of pain during/after sexual activity 1.39 2.54
Level of pain during/after sexual activity 1.26 2.57
Fear that sex will be painful 1.06 2.46
Fear of injury during intercourse 0.87 2.08
HCPs, health care professionals.
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interesting to further investigate.
Strength of the study is the fact that the development 
of the sexual health questionnaire is based on current 
literature, patient and HCP interviews from many different 
countries according to the EORTC guidelines (21). The 
literature review systematically examined sexual health 
issues in cancer beyond general ratings of sexual activity, 
symptoms, and sexual dysfunction. As other literature 
reviews (25-28) have described patients’ sexual activities, 
types of sexual dysfunction and generic levels of sexual 
satisfaction, this review uniquely took as its focus sexual 
health issues for all cancer patients and survivors. Including 
interviews of more than 100 patients with different cancer 
sites and many professionals from different disciplines 
also increases the quality of the development process. 
The provisional module will then be pre-tested in various 
languages to identify and solve potential problems with 
wording. For pilot-testing patients from many different 
countries and cultures are foreseen (phase 3) after the 
translation process was finished and ethical approval was 
done. Also the translations into several languages and the 
cross cultural distributions for developing the questions 
follow a standardized procedure (18). The questions are 
designed for male and female patients with different cancer 
sites during all stages of their disease. 
It is suggested that future studies broaden their focus to 
encompass sexual health related topics (body image, self-
esteem, relationship functioning and communication) rated 
as important in cancer survivors which is not evident yet. 
But these issues should be addressed in clinical trials to 
get information on a possible impact for clinical practice. 
The instrument will be designed as a ‘stand-alone’ sexual 
health measure that can be used in clinical trials as well as 
in clinical studies. The results of trials which use the sexual 
health questionnaire adequately can improve sexual health 
care.
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